Skip to content
GenoLensGenoLens

PURA

Chr 5q31.3

purine rich element binding protein A

Aliases:
PURALPHA, PUR1, PUR-ALPHA
MANE:
ENST00000331327.5

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation

    0.78
  • Intellectual disability

    0.71
  • PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome

    0.58
  • hereditary disease

    0.55
  • neurodegenerative disease

    0.53
  • Global developmental delay

    0.52
  • Delayed speech and language development

    0.52
  • Neonatal hypotonia

    0.52
  • Seizure

    0.51
  • autosomal dominant non-syndromic intellectual disability

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Transcriptional activator protein Pur-alpha

This is a probable transcription activator that specifically binds the purine-rich single strand of the PUR element located upstream of the MYC gene (PubMed:1448097, PubMed:20976240). May play a role in the initiation of DNA replication and in recombination

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.